great post dd.
our product is a fantastic offering and I think there is no doubt that care providers across Australia will use our product and I highly doubt there will be any churn - makes their life easier, adds clinical efficiency and no competitors - simple really. I fully expect the Australian government to continue funding it to be honest, obviously that's in line with KPMG study - totally independent findings.
this isn't an isolated issue to Australia, though - other countries face the same and I wouldn't be surprised if the UK government threw some money our way... although with downloads it doesn't seem to be a big issue
- Forums
- ASX - By Stock
- PainChek General Discussion
great post dd.our product is a fantastic offering and I think...
-
- There are more pages in this discussion • 5,278 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.8¢ |
Change
-0.003(9.68%) |
Mkt cap ! $45.84M |
Open | High | Low | Value | Volume |
2.8¢ | 2.9¢ | 2.8¢ | $64.49K | 2.298M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38188 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38188 | 0.028 |
4 | 1287037 | 0.027 |
4 | 1040000 | 0.026 |
4 | 1159601 | 0.025 |
1 | 41252 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 65000 | 1 |
0.031 | 18000 | 1 |
0.032 | 89187 | 1 |
0.033 | 100000 | 1 |
0.034 | 108791 | 1 |
Last trade - 15.14pm 12/11/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online